|
|
|
| Industry update |
| //French biotech company DEINOVE appointed Alexis RIDEAU as CEO.
//AstraZeneca appointed Tom Keith-Roach as President of its UK business. Keith-Roach joins the AZ UK team following a number of in-country, above-country and global therapy area leadership positions.
//Crescendo Biologics (Cambridge, UK) appointed Kenji Hashimoto as Chief Medical Officer.
//Genmab (Copenhagen, Denmark) appointed Anthony Mancini as Executive Vice President and to the newly created position of Chief Operating Officer.
//Galecto (Copenhagen, Denmark), a clinical stage company developing treatments for fibrosis and cancer, appointed Bertil Lindmark as Chief Medical Officer.
|
|
|
|
|
|
|
|
|
| Emerging Markets |
 |
|
Iraq: Stabilizing a Growing Market |
Ali Mosawi writes about the misconceptions of Iraq's often inhospitable landscape, the essential role of international expertise in driving growth, and how the pharma sector has adapted to meet the challenges of the COVID-19 pandemic
… Read more |
|
|
|
|
| Audio |
 |
|
The Pharm Exec Podcast: Developing a Maternal RSV Vaccine |
Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal vaccine for respiratory syncytial virus, also known as RSV, currently being administered to pregnant women in trials, in the hopes of protecting their infants
… Click here to listen |
|
|
|
| COVID-19 |
 |
|
|
|
|
Register Now
